Patents by Inventor Heike Göhler

Heike Göhler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for diagnosis of high-affinity binders and marker sequences
    Patent number: 10060911
    Abstract: The present invention relates to a novel method for diagnosing high-affinity binders, in particular antibodies or autoantibodies, and the identification, characterization and selection of marker sequences and diagnostic use thereof, in particular in the form of a panel. The invention also relates to a singleplex assay in which the discovered selection of marker sequences is used in the form of a panel and high-affinity binders are detected using a single signal.
    Type: Grant
    Filed: August 18, 2012
    Date of Patent: August 28, 2018
    Assignee: Protagen Aktiengesellschaft
    Inventors: Stefan Müllner, Peter Schulz-Knappe, Angelika Lueking, Heike Göhler, Jessica Schwermann
  • Method for the diagnosis of neuromyelitis optica
    Patent number: 10036746
    Abstract: The present invention relates to a method for the diagnosis and/or risk stratification of neuromyelitis optica (abbreviated NMO), wherein a determination from a body sample of a patient/test subject is performed by means of artificial aquaporin-4 peptides. The invention further relates to a kit and to new artificial aquaporin-4 peptides as such.
    Type: Grant
    Filed: January 12, 2017
    Date of Patent: July 31, 2018
    Assignee: PROTAGEN AG
    Inventors: Heike Göhler, Petra Rengers, Angelika Lüking, Stefan Müllner
  • METHOD FOR THE DIAGNOSIS OF NEUROMYELITIS OPTICA
    Publication number: 20170115288
    Abstract: The present invention relates to a method for the diagnosis and/or risk stratification of neuromyelitis optica (abbreviated NMO), wherein a determination from a body sample of a patient/test subject is performed by means of artificial aquaporin-4 peptides. The invention further relates to a kit and to new artificial aquaporin-4 peptides as such.
    Type: Application
    Filed: January 12, 2017
    Publication date: April 27, 2017
    Inventors: Heike Göhler, Petra Rengers, Angelika LÜKING, Stefan MÜLLNER
  • Method for the diagnosis of neuromyelitis optica
    Patent number: 9588115
    Abstract: The present invention relates to a method for the diagnosis and/or risk stratification of neuromyelitis optica (abbreviated NMO), wherein a determination from a body sample of a patient/test subject is performed by means of artificial aquaporin-4 peptides. The invention further relates to a kit and to new artificial aquaporin-4 peptides as such.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: March 7, 2017
    Assignee: PROTAGEN AG
    Inventors: Heike Göhler, Petra Rengers, Angelika Lüking, Stefan Müllner
  • METHOD FOR THE DIAGNOSIS OF NEUROMYELITIS OPTICA
    Publication number: 20160054318
    Abstract: The present invention relates to a method for the diagnosis and/or risk stratification of neuromyelitis optica (abbreviated NMO), wherein a determination from a body sample of a patient/test subject is performed by means of artificial aquaporin-4 peptides. The invention further relates to a kit and to new artificial aquaporin-4 peptides as such.
    Type: Application
    Filed: March 28, 2014
    Publication date: February 25, 2016
    Inventors: Heike GÖHLER, Petra RENGWRS, Angelika LÜKING, Stefan MÜLLNER
  • MARKER SEQUENCES FOR NEUROMYELITIS OPTICA (NMO) AND USE THEREOF
    Publication number: 20150323529
    Abstract: The present invention relates to new markers for Neuromyelitis Optica (NMO), a method for identifying markers for NMO, the use of the markers identified by the method, diagnostic devices, panels of markers, assays, protein arrays comprising markers for NMO and a method for detecting NMO.
    Type: Application
    Filed: November 27, 2013
    Publication date: November 12, 2015
    Inventors: Heike GÖHLER, Marquart KLAUS, Andrew CHAN, Peter SCHULZ-KNAPPE, Carmen THEEK, Anna TELAAR, Martin GAMER
  • MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS
    Publication number: 20150293120
    Abstract: The present invention relates to a novel method for identifying marker sequences for rheumatoid arthritis, the novel marker sequences discovered with the aid of the method, and the diagnostic use thereof. The invention also relates to diagnostic devices containing such marker sequences for rheumatoid arthritis, in particular a protein biochip or beads (pellets), and use thereof.
    Type: Application
    Filed: March 27, 2013
    Publication date: October 15, 2015
    Inventors: Angelika LÜKING, Peter SCHULZ-KNAPPE, Heike GÖHLER, Martin GAMER, Carmen THEEK, Daniel CHAMRAD, Anna TELAAR, Matthias VON DARL, Matthias SCHNEIDER, Jessica SCHWERMANN
  • Novel Method for Diagnosis of High-Affinity Binders and Marker Sequences
    Publication number: 20140309133
    Abstract: The present invention relates to a novel method for diagnosing high-affinity binders, in particular antibodies or autoantibodies, and the identification, characterisation and selection of marker sequences and diagnostic use thereof, in particular in the form of a panel. The invention also relates to a singleplex assay in which the discovered selection of marker sequences is used in the form of a panel and high-affinity binders are detected using a single signal.
    Type: Application
    Filed: August 18, 2012
    Publication date: October 16, 2014
    Applicant: Protagen Aktinegesellschaft
    Inventors: Stefan Müllner, Peter Schulz-Knappe, Angelika Lueking, Heike Göhler, Jessica Schwermann
  • MARKER SEQUENCES FOR MULTIPLE SCLEROSIS AND USE THEREOF
    Publication number: 20140018245
    Abstract: The invention relates to novel marker sequences for multiple sclerosis and to the use thereof in diagnosis as well as to a method for screening potential active ingredients for multiple sclerosis diseases using said marker sequences. The invention further relates to a diagnostic device containing such marker sequences for multiple sclerosis, especially to a protein biochip and the use thereof.
    Type: Application
    Filed: October 12, 2011
    Publication date: January 16, 2014
    Applicant: PROTAGEN Aktiengesellschaft
    Inventors: Angelika Lueking, Axel Kowald, Heike Göhler
  • Marker Sequences for Multiple Sclerosis and Use Thereof
    Publication number: 20130244897
    Abstract: The invention relates to novel marker sequences for multiple sclerosis and to the use thereof in diagnosis as well as to a method for screening potential active ingredients for multiple sclerosis diseases the marker sequences. The invention further relates to a diagnostic device containing such marker sequences for multiple sclerosis, especially to a protein biochip and the use thereof.
    Type: Application
    Filed: October 4, 2011
    Publication date: September 19, 2013
    Applicant: Protagen AG
    Inventors: Angelika Lueking, Axel Kowald, Heike Göhler
  • MARKER SEQUENCE FOR NEURODEGENERATIVE DISEASES AND THE USE THEREOF
    Publication number: 20110184375
    Abstract: The present invention relates to new marker sequences for neurodegenerative diseases and the diagnostic use thereof together with a method for screening of potential active substances for neurodegenerative diseases by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for neurodegenerative diseases, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: December 22, 2008
    Publication date: July 28, 2011
    Applicant: Protagen Aktiengesellschaft
    Inventors: Heike Göhler, Helmut E. Meyer, Katrin Marcus, Axel Kowald, Florian Tribl, Manfred Gerlach, Peter Riederer, Angelika Lüking, Christian Scheer, Jens Beator